Homing in on acute graft vs. host disease: Tissue-specific T regulatory and TH17 cells

Current Topics in Microbiology and Immunology

Volumn 341, Issue 1, 2010, Pages 121-146

  Engelhardt, Brian G ^a   Crowe, James E ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE RECEPTOR; INTEGRIN; INTERLEUKIN 6; RETINOIC ACID; SELECTIN; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT VERSUS HOST DISEASE; ADAPTIVE IMMUNITY; ARTICLE; DENDRITIC CELL; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; INNATE IMMUNITY; INTESTINE; LUNG; LYMPH NODE; LYMPHOCYTE HOMING; MORBIDITY; MORTALITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SKIN; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; ANIMAL; ANTIBODY SPECIFICITY; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; IMMUNOLOGY; MALE; MOUSE;

ANIMALS; CELL ADHESION MOLECULES; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MICE; ORGAN SPECIFICITY; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 79952059754     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-2     Document Type: Article

References (136)

1. Acosta-Rodriguez EV et al (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8(6):639-646 (Pubitemid 46785128)
2. Agace WW (2006) Tissue-tropic effector T cells: Generation and targeting opportunities. Nat Rev Immunol 6(9):682-692 (Pubitemid 44298217)
3. Allen RD, Staley TA, Sidman CL (1993) Differential cytokine expression in acute and chronic murine graft-versus-host-disease. Eur J Immunol 23(2):333-337 (Pubitemid 23075059)
4. Alousi AM et al (2009) Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: A randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood 114(3):511-517
5. Arai S, Vogelsang GB (2000) Management of graft-versus-host disease. Blood Rev 14(4): 190-204 (Pubitemid 32098008)
6. Arbones ML et al (1994) Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficient mice. Immunity 1(4):247-260
7. Aujla SJ et al (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14(3):275-281 (Pubitemid 351347908)
8. Beatty PG et al (1985) Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 313(13):765-771 (Pubitemid 15232310)
9. Beatty PG et al (1991) Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. Transplantation 51(2):443-447
10. Beilhack A et al (2005) In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets. Blood 106(3):1113-1122 (Pubitemid 41076462)
11. Beilhack A et al (2008) Prevention of acute graft-versus-host disease by blocking T-cell entry to secondary lymphoid organs. Blood 111(5):2919-2928
12. Belkaid Y et al (2002) CD4+ CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420(6915):502-507 (Pubitemid 35477041)
13. Berg EL et al (1991) The human peripheral lymph node vascular addressin is a ligand for LECAM- 1, the peripheral lymph node homing receptor. J Cell Biol 114(2):343-349 (Pubitemid 21909805)
14. Berlin C et al (1993) Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell 74(1):185-195 (Pubitemid 23219889)
15. Bettelli E et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235-238
16. Bettelli E, OukkaM, Kuchroo VK (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8(4):345-350 (Pubitemid 46745409)
17. Carlson MJ et al (2009) In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 113 (6):1365-1374
18. Chen W et al (2003) Conversion of peripheral CD4+ CD25- naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198(12):1875-1886 (Pubitemid 38032120)
19. Chen X et al (2009) Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease. Blood 114(4):891-900
20. Chung DJ et al (2009) Indoleamine 2, 3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood 114(3):555-563
21. Cohen JL et al (2002) CD4(+)CD25(+) immunoregulatory T Cells: New therapeutics for graftversus- host disease. J Exp Med 196(3):401-406 (Pubitemid 34875668)
22. Curiel TJ et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942-949 (Pubitemid 39273735)
23. Curti A et al (2009) The role of indoleamine 2, 3-dioxygenase in the induction of immune tolerance: Focus on hematology. Blood 113(11):2394-2401
24. Deaglio S et al (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204(6):1257-1265 (Pubitemid 46919862)
25. Dominitzki S et al (2007) Cutting edge: Trans-signaling via the soluble IL-6R abrogates the induction of FoxP3 in naive CD4+ CD25 T cells. J Immunol 179(4):2041-2045
26. Dudda JC et al (2005) Dendritic cells govern induction and reprogramming of polarized tissueselective homing receptor patterns of T cells: Important roles for soluble factors and tissue microenvironments. Eur J Immunol 35(4):1056-1065 (Pubitemid 40542212)
27. EdingerMet al (2003) CD4+ CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9(9):1144-1150 (Pubitemid 37173698)
28. Elias KM et al (2008) Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111(3):1013-1020 (Pubitemid 351213378)
29. Engelhardt B et al (2008) Circulating gut- or skin-homing regulatory T cells (tregs) predict whether acute graft-versus-host disease (aGVHD) occurs in gut or skin following allogeneic stem cell transplantation (ASCT). Blood 112(11):264a
30. Ermann J et al (2005) Only the CD62L+ subpopulation of CD4+ CD25+ regulatory T cells protects from lethal acute GVHD. Blood 105(5):2220-2226 (Pubitemid 40731816)
31. Ferrara JL, Levy R, Chao NJ (1999) Pathophysiologic mechanisms of acute graft-vs.-host disease. Biol Blood Marrow Transplant 5(6):347-356
32. Filipovich AH et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11(12):945-956 (Pubitemid 41754712)
33. Fondi C et al (2009) Increase in FOXP3+ regulatory T cells in GVHD skin biopsies is associated with lower disease severity and treatment response. Biol Blood Marrow Transplant 15(8): 938-947
34. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 4(4):330-336 (Pubitemid 36432314)
35. Gavin MA et al (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 103(17):6659-6664
36. Gershon RK, Kondo K (1970) Cell interactions in the induction of tolerance: The role of thymic lymphocytes. Immunology 18(5):723-737
37. Graubert TA et al (1997) Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J Clin Invest 100(4):904-911 (Pubitemid 27371709)
38. Gunn MD et al (1998) A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes. Proc Natl Acad Sci USA 95(1):258-263 (Pubitemid 28103941)
39. Hanash AM, Levy RB (2005) Donor CD4+ CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood 105(4):1828-1836 (Pubitemid 40223710)
40. Hoffmann P et al (2002) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196(3):389-399 (Pubitemid 34875667)
41. Hoffmann P et al (2004) Large-scale in vivo expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104(3):895-903 (Pubitemid 38970590)
42. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299(5609):1057-1061 (Pubitemid 36222930)
43. Huehn J, Hamann A (2005) Homing to suppress: Address codes for Treg migration. Trends Immunol 26(12):632-636 (Pubitemid 41628195)
44. Huehn J et al (2004) Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 199(3):303-313 (Pubitemid 38252043)
45. Ivanov II, Zhou L, Littman DR (2007) Transcriptional regulation of Th17 cell differentiation. Semin Immunol 19(6):409-417 (Pubitemid 351274050)
46. Iwata M et al (2004) Retinoic acid imprints gut-homing specificity on T cells. Immunity 21(4):527-538 (Pubitemid 39370508)
47. Izcue A, Coombes JL, Powrie F (2006) Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 212:256-271 (Pubitemid 44116713)
48. Jasperson LK et al (2009) Inducing the tryptophan catabolic pathway, indoleamine 2, 3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. Blood 114(24):5062-5070
49. Jones SC, Murphy GF, Korngold R (2003) Post-hematopoietic cell transplantation control of graftversus- host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant 9(4):243-256 (Pubitemid 40045611)
50. Kang SG et al (2007) Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol 179(6):3724-3733
51. Kappel LW et al (2009) IL-17 contributes to CD4-mediated graft-versus-host disease. Blood 113(4):945-952
52. Kim CH (2006) Migration and function of FoxP3+ regulatory T cells in the hematolymphoid system. Exp Hematol 34(8):1033-1040 (Pubitemid 44080379)
53. Kim CH (2008) Regulation of FoxP3 regulatory T cells and Th17 cells by retinoids. Clin Dev Immunol 2008:416910
54. Kim CH (2009) Migration and function of Th17 cells. Inflamm Allergy Drug Targets 8(3): 221-228
55. Kim YM et al (2003) Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720. J Clin Invest 111(5):659-669
56. Kim TD et al (2008) Organ-derived dendritic cells have differential effects on alloreactive T cells. Blood 111(5):2929-2940
57. Lee JH, Kang SG, Kim CH (2007) FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J Immunol 178(1):301-311 (Pubitemid 46033613)
58. Leeuwenberg JF et al (1988) Effects of tumor necrosis factor on the interferon-gamma-induced major histocompatibility complex class II antigen expression by human endothelial cells. Eur J Immunol 18(9):1469-1472
59. Lim HW, Broxmeyer HE, Kim CH (2006) Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol 177(2):840-851 (Pubitemid 44036584)
60. Lim HW et al (2008) Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J Immunol 180(1):122-129
61. LiuW et al (2006) CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 203(7):1701-1711 (Pubitemid 44036276)
62. Lowsky R et al (2005) Protective conditioning for acute graft-versus-host disease. N Engl J Med 353(13):1321-1331 (Pubitemid 41362700)
63. Mangan PR et al (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441(7090):231-234
64. Martin PJ et al (1990) A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood 76(8):1464-1472 (Pubitemid 20364008)
65. Martin PJ et al (1991) A retrospective analysis of therapy for acute graft-versus-host disease: Secondary treatment. Blood 77(8):1821-1828
66. Mielke S et al (2007) Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood 110(5):1689-1697 (Pubitemid 47443988)
67. Miossec P, Korn T, Kuchroo VK (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361(9):888-898
68. Miura Y et al (2004) Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 104(7):2187-2193 (Pubitemid 39297878)
69. Mora JR et al (2005) Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J Exp Med 201(2):303-316 (Pubitemid 40189439)
70. Morgan ME et al (2005) Expression of FOXP3 mRNA is not confined to CD4+ CD25+T regulatory cells in humans. Hum Immunol 66(1):13-20 (Pubitemid 40037706)
71. Mucida D et al (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317(5835):256-260 (Pubitemid 47076203)
72. Murai M et al (2003) Peyer's patch is the essential site in initiating murine acute and lethal graftversus- host reaction. Nat Immunol 4(2):154-160 (Pubitemid 36193017)
73. Nadal E et al (2007) Increased frequencies of CD4(+)CD25(high) T(regs) correlate with disease relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leukemia 21(3):472-479
74. Nash RA et al (1992) Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 80(7):1838-1845
75. Nguyen VH et al (2007) In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood 109(6):2649-2656 (Pubitemid 46425916)
76. Norton J, Sloane JP (1991) ICAM-1 expression on epidermal keratinocytes in cutaneous graftversus- host disease. Transplantation 51(6):1203-1206
77. Oswald-Richter K et al (2004) HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol 2(7):E198
78. Ouyang W, Kolls JK, Zheng Y (2008) The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28(4):454-467 (Pubitemid 351471762)
79. Pabst C et al (2007) The graft content of donor T cells expressing gamma delta TCR+ and CD4+ foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors. Clin Cancer Res 13(10): 2916-2922 (Pubitemid 46849566)
80. Pandiyan P et al (2007) CD4+ CD25+ Foxp3+ regulatory T cells induce cytokine deprivationmediated apoptosis of effector CD4+ T cells. Nat Immunol 8(12):1353-1362 (Pubitemid 350131172)
81. Picker LJ et al (1993) Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 50(3):1122-1136 (Pubitemid 23133692)
82. Piguet PF et al (1987) Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease. J Exp Med 166(5):1280-1289
83. Przepiorka D et al (2001) Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 98(6):1695-1700
84. Qin HY et al (2006) A novel mechanism of regulatory T cell-mediated down-regulation of autoimmunity. Int Immunol 18(7):1001-1015
85. Reddy P (2003) Pathophysiology of acute graft-versus-host disease. Hematol Oncol 21(4): 149-161 (Pubitemid 38146266)
86. Rezvani K et al (2006) High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT. Blood 108(4):1291-1297 (Pubitemid 44232027)
87. Rieger K et al (2006) Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD. Blood 107(4):1717-1723 (Pubitemid 43242414)
88. Sackstein R (2006) A revision of Billingham's tenets: The central role of lymphocyte migration in acute graft-versus-host disease. Biol Blood Marrow Transplant 12(1 Suppl 1):2-8 (Pubitemid 43034112)
89. Sakaguchi S, Sakaguchi N, Asano M et al (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155(3): 1151-1164
90. Sanchez J et al (2004) Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol 126(5):697-703 (Pubitemid 39221306)
91. Sato W, Aranami T, Yamamura T (2007) Cutting edge: Human Th17 cells are identified as bearing CCR2+CCR5- phenotype. J Immunol 178(12):7525-7529 (Pubitemid 46898020)
92. Schambach F et al (2007) Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 37(9):2396-2399 (Pubitemid 47423609)
93. Seddiki N et al (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203(7):1693-1700 (Pubitemid 44036275)
94. Seidel MG et al (2006) Expression of the putatively regulatory T-cell marker FOXP3 by CD4(+) CD25+ T cells after pediatric hematopoietic stem cell transplantation. Haematologica 91(4):566-569
95. Sharma MD et al (2009) Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 113(24):6102-6111
96. Shevach EM (2002) CD4+ CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2(6):389-400 (Pubitemid 37328746)
97. Shimizu J et al (2002) Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3(2):135-142 (Pubitemid 34141443)
98. Shlomchik WD (2007) Graft-versus-host disease. Nat Rev Immunol 7(5):340-352 (Pubitemid 46674485)
99. Shlomchik WD et al (1999) Prevention of graft versus host disease by inactivation of host antigenpresenting cells. Science 285(5426):412-415 (Pubitemid 29343964)
100. Shresta S et al (1998) How do cytotoxic lymphocytes kill their targets? Curr Opin Immunol 10(5):581-587 (Pubitemid 28479192)
101. Siewert C et al (2007) Induction of organ-selective CD4+ regulatory T cell homing. Eur J Immunol 37(4):978-989 (Pubitemid 46925335)
102. Sigmundsdottir H, Butcher EC (2008) Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat Immunol 9(9):981-987
103. Sigmundsdottir H et al (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8(3):285-293 (Pubitemid 46745378)
104. Singh SP et al (2008) Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 180(1):214-221
105. Socie G, Blazar BR (2009) Acute graft-versus-host disease: From the bench to the bedside. Blood 114(20):4327-4336
106. Stanzani M et al (2004) CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans. Blood 103(3):1140-1146 (Pubitemid 38129583)
107. Szanya V et al (2002) The subpopulation of CD4+ CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J Immunol 169(5):2461-2465 (Pubitemid 34920990)
108. Takahashi T et al (1998) Immunologic self-tolerance maintained by CD25+ CD4+ naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/ suppressive state. Int Immunol 10(12):1969-1980 (Pubitemid 28566059)
109. Takahashi T et al (2000) Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 192(2):303-310
110. Tang Q, Bluestone JA (2008) The Foxp3+ regulatory T cell: A jack of all trades, master of regulation. Nat Immunol 9(3):239-244 (Pubitemid 351267321)
111. Taylor PA, Noelle RJ, Blazar BR (2001) CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193(11): 1311-1318
112. Taylor PA, Lees CJ, Blazar BR (2002) The infusion of ex vivo activated and expanded CD4(+) CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99(10):3493-3499 (Pubitemid 34534513)
113. Taylor PA et al (2004) L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood 104(12):3804-3812 (Pubitemid 39564461)
114. Thornhill MH et al (1991) Tumor necrosis factor combines with IL-4 or IFN-gamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and - independent binding mechanisms. J Immunol 146(2):592-598
115. Thornton AM, Shevach EM (1998) CD4+ CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vivo by inhibiting interleukin 2 production. J Exp Med 188(2):287-296 (Pubitemid 28357757)
116. Trenado A et al (2003) Recipient-type specific CD4+ CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 112(11):1688-1696 (Pubitemid 38063726)
117. Varona R et al (2006) CCR6 regulates the function of alloreactive and regulatory CD4+ T cells during acute graft-versus-host disease. Leuk Lymphoma 47(8):1469-1476 (Pubitemid 44364009)
118. Via CS, Finkelman FD (1993) Critical role of interleukin-2 in the development of acute graftversus- host disease. Int Immunol 5(6):565-572 (Pubitemid 23209409)
119. Via CS et al (1996) A major role for the Fas pathway in acute graft-versus-host disease. J Immunol 157(12):5387-5393 (Pubitemid 126448957)
120. Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8(7):523-532
121. von Andrian UH, Mempel TR (2003) Homing and cellular traffic in lymph nodes. Nat Rev Immunol 3(11):867-878 (Pubitemid 37411716)
122. Wang J et al (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37(1):129-138 (Pubitemid 46128793)
123. Wang R et al (2008) Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS One 3(7):e2705
124. Wei S, Kryczek I, Zou W (2006) Regulatory T-cell compartmentalization and trafficking. Blood 108(2):426-431 (Pubitemid 44061338)
125. Weisdorf D et al (1991) Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51(6):1197-1203
126. Welniak LA, Blazar BR, Murphy WJ (2007) Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 25:139-170 (Pubitemid 46697905)
127. Wolf D et al (2007) Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Transplantation 83(8):1107-1113 (Pubitemid 46659123)
128. Wysocki CA et al (2005a) Leukocyte migration and graft-versus-host disease. Blood 105 (11):4191-4199 (Pubitemid 40720762)
129. Wysocki CA et al (2005b) Critical role for CCR5 in the function of donor CD4+ CD25+ regulatory T cells during acute graft-versus-host disease. Blood 106(9):3300-3307 (Pubitemid 41565933)
130. Xiao S et al (2008) Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181(4):2277-2284
131. Xu H et al (2008) IDO: A double-edged sword for T(H)1/T(H)2 regulation. Immunol Lett 121(1):1-6
132. Xun CQ et al (1994) Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice. Blood 83(8):2360-2367
133. Yamaguchi T et al (2007) Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27(1):145-159 (Pubitemid 47089022)
134. Yi T et al (2008) Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood 112(5):2101-2110
135. Yi T et al (2009) Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood 114(14):3101-3112
136. Zhang Y et al (2005) Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat Med 11(12):1299-1305 (Pubitemid 41752910)